SCHEMBL2180336

SCHEMBL2180336

CN(C)CCNCCOc1nnc2c(n1)c(=O)n(C)c(=O)n2-c1ccc(F)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.35
ALDH1A1 P00352 3/20 0.35
GAA P10253 1/20 0.35
KDM4E B2RXH2 2/20 0.34
ADORA2A P29274 4/20 0.34
ADORA1 P30542 3/20 0.34
ADORA3 P0DMS8 1/20 0.34
ADORA2B P29275 1/20 0.34
PKM P14618 1/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33
HSD17B10 Q99714 1/20 0.33
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
CYP2D6 P10635 1/20 0.33
RXFP1 Q9HBX9 1/20 0.32
ATM Q13315 2/20 0.32
TP53 P04637 1/20 0.32
DCTPP1 Q9H773 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2181265 0.98 POLB (0.38) POLBSMN1; SMN2ALDH1A1GAAKDM4E
SCHEMBL2183997 0.91 POLB (0.37) POLBSMN1; SMN2ALDH1A1KDM4EADORA2A
SCHEMBL2179957 0.90 ADORA2A (0.41) POLBSMN1; SMN2ALDH1A1ADORA2AADORA1
SCHEMBL2182844 0.89 SMN1; SMN2 (0.45) POLBSMN1; SMN2KDM4EADORA2AADORA1
SCHEMBL2180279 0.89 POLB (0.37) POLBSMN1; SMN2ALDH1A1KDM4EADORA2A
SCHEMBL2180836 0.89 POLB (0.39) POLBSMN1; SMN2TSHRMAOAMAOB
SCHEMBL2184174 0.87 POLB (0.39) POLBSMN1; SMN2ALDH1A1KDM4ETSHR
SCHEMBL2183502 0.86 POLB (0.41) POLBSMN1; SMN2ALDH1A1TSHRHSD17B10
SCHEMBL2183434 0.86 POLB (0.42) POLBSMN1; SMN2ALDH1A1KDM4EADORA2A
SCHEMBL3261228 0.85 POLB (0.41) POLBSMN1; SMN2ALDH1A1TSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110166144-A1 Pyrimidotriazinediones and Pyrimidopyrimidinediones and Methods of Using the Same THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166144-A1 Pyrimidotriazinediones and Pyrimidopyrimidinediones and Methods of Using the Same DPYD, TYMP, DHFR POLB 312/4885SMN1; SMN2 2741/4885ALDH1A1 245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.